Aram J. Chung

Aram J. Chung

Auto-generated profile, based on publicly available information

Aram J. Chung

Department of Bioengineering Korea University Seoul Republic of Korea

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2019 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
GXGuoqing Xin
Guoqing Xin
WZWeiguang Zhu
Weiguang Zhu
YDYanxiang Deng
Yanxiang Deng
JCJie Cheng
Jie Cheng
LZLucy T. Zhang
Lucy T. Zhang
JLJie Lian
Jie Lian

8 January 2009 in Microfluidics and Nanofluidics
Verified
Journal Article
Closed access
PDF file
YHYun Suk Huh
Yun Suk Huh
ACAram J. Chung
Aram J. Chung
DEDavid C Erickson
David C Erickson

12 November 2012 in Small
Verified
Journal Article
Closed access
PDF file
ACAram J. Chung
Aram J. Chung
DGDaniel R. Gossett
Daniel R. Gossett
DCDino Di Carlo
Dino Di Carlo

10 December 2015 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
ZWZhenlong Wu
Zhenlong Wu
YCYu Chen
Yu Chen
MWMoran Wang
Moran Wang
ACAram J. Chung
Aram J. Chung
Fluid inertia which has conventionally been neglected in microfluidics has been gaining much attention for particle and cell manipulation because inertia-based methods inherently provide simple, passive, precise and high-throughput characteristics. Particularly, the inertial approach has been applied to blood separation for various biomedical research studies mainly using spiral microchannels. For higher throughput, parallelization is essential; however, it is difficult to realize using spiral channels because of their large two dimensional layouts. In this work, we present a novel inertial platform for continuous sheathless particle and blood cell separation in straight microchannels containing microstructures. Microstructures within straight channels exert secondary flows to manipulate particle positions similar to Dean flow in curved channels but with higher controllability. Through a balance between inertial lift force and microstructure-induced secondary flow, we deterministically position microspheres and cells based on their sizes to be separated downstream. Using our inertial platform, we successfully sorted microparticles and fractionized blood cells with high separation efficiencies, high purities and high throughputs. The inertial separation platform developed here can be operated to process diluted blood with a throughput of 10.8 mL min−1via radially arrayed single channels with one inlet and two rings of outlets.

23 April 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
KPKevin S. Paulsen
Kevin S. Paulsen
DCDino Di Carlo
Dino Di Carlo
ACAram J. Chung
Aram J. Chung
Complex three-dimensional (3D)-shaped particles could play unique roles in biotechnology, structural mechanics and self-assembly. Current methods of fabricating 3D-shaped particles such as 3D printing, injection moulding or photolithography are limited because of low-resolution, low-throughput or complicated/expensive procedures. Here, we present a novel method called optofluidic fabrication for the generation of complex 3D-shaped polymer particles based on two coupled processes: inertial flow shaping and ultraviolet (UV) light polymerization. Pillars within fluidic platforms are used to deterministically deform photosensitive precursor fluid streams. The channels are then illuminated with patterned UV light to polymerize the photosensitive fluid, creating particles with multi-scale 3D geometries. The fundamental advantages of optofluidic fabrication include high-resolution, multi-scalability, dynamic tunability, simple operation and great potential for bulk fabrication with full automation. Through different combinations of pillar configurations, flow rates and UV light patterns, an infinite set of 3D-shaped particles is available, and a variety are demonstrated.

6 June 2021 in Advanced Science
Verified
Journal Article
Open access
PDF file
JHJeongsoo Hur
Jeongsoo Hur
ACAram J. Chung
Aram J. Chung
Innate cell function can be artificially engineered and reprogrammed by introducing biomolecules, such as DNAs, RNAs, plasmid DNAs, proteins, or nanomaterials, into the cytosol or nucleus. This process of delivering exogenous cargos into living cells is referred to as intracellular delivery. For instance, clustered regularly interspaced short palindromic repeats (CRISPR)‐Cas9 gene editing begins with internalizing Cas9 protein and guide RNA into cells, and chimeric antigen receptor‐T (CAR‐T) cells are prepared by delivering CAR genes into T lymphocytes for cancer immunotherapies. To deliver external biomolecules into cells, tools, including viral vectors, and electroporation have been traditionally used; however, they are suboptimal for achieving high levels of intracellular delivery while preserving cell viability, phenotype, and function. Notably, as emerging solutions, microfluidic and nanofluidic approaches have shown remarkable potential for addressing this open challenge. This review provides an overview of recent advances in microfluidic and nanofluidic intracellular delivery strategies and discusses new opportunities and challenges for clinical applications. Furthermore, key considerations for future efforts to develop microfluidics‐ and nanofluidics‐enabled next‐generation intracellular delivery platforms are outlined.